XERS — Xeris Biopharma Holdings Share News
0.000.00%
Last trade - 00:00- $1.84bn
- $1.97bn
- $291.85m
Brief: Xeris Enters Into An Exclusive Worldwide Collaboration And License Agreement With Beta Bionics
Brief: Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Xeris Biopharma Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: Xeris Refinances Its $150M Senior Secured Term Loan Facility
Brief: Xeris Biopharma Q4 Net Income USD -13.39 Million
Xeris Biopharma Holdings Inc expected to post a loss of 10 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Virgin Galactic, Meta Platforms, EchoStar
U.S. STOCKS ON THE MOVE-Palo Alto Networks, Masimo, Tigo Energy
U.S. STOCKS ON THE MOVE-Intuitive Surgical, Home Depot, SMART Global
Xeris climbs on Amgen collaboration to develop eye disease treatment
Brief: Xeris Biopharma Enters Into Exclusive License Agreement For Xeriject
Brief: Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Crypto stocks, US insurers, EPAM Systems
U.S. STOCKS ON THE MOVE-Apple, Lamb Weston, Dyne Therapeutics
Xeris sees FY23 revenue at top end of forecast range; shares rise
Brief: Xeris Biopharma Reports Third Quarter 2023 Financial Results
Brief: Xeris Biopharma Q3 Net Income USD -12.189 Million
Xeris Biopharma Holdings Inc reports results for the quarter ended in June - Earnings Summary
Brief: Xeris Biopharma Q2 Net Income USD -19.842 Million